Lichen China Limited (Nasdaq: LICN) ('Lichen China' or the 'Company'), a dedicated financial and taxation service provider in China today announced that it has received a letter from The Nasdaq Stock ...

If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025Priority ...

Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoidIf approved, Dupixent would be the first and only ...

The US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults with bullous pemphigoid (BP).

If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025 Priority Review granted based on positive pivotal results demonstrat ...

Whether you’re trying to grow out your hair or think you may be noticing the early signs of balding, you may be wondering ...

Such is the joy of road trips with young adults: not once do they ask if we’re there yet. Instead they curate playlists, ...

In December of the following year, the Scottish Government begun referring to nature and climate as a twin crisis. Cunningham informed parliament of plans to protect at least 30 per cent of Scotland’s ...

In the days after the massive 1906 earthquake and fire in San Francisco, dispatches from historic Bay Area towns were shades of grim and horrific. “SAN JOSE IS RUINED,” “SANTA ROSA IS A TOTAL WRECK” ...

XIAMEN, China - Lichen China Limited (NASDAQ: LICN), a prominent financial and taxation service provider with impressive gross profit margins of 60.71% and a strong financial... Lichen China ...

“A lot of people hear ‘Part A,’ ‘Part B,’ ‘Plan F’ and all these different letters flying around, and they definitely get a little confused,” says Sterling Price, a senior research ...